Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Zealand Completes Funding, Seeks New ZP10 Partnership

April 2, 2003

By Cormac Sheridan

Irish Delegation Visiting NIH To Seek Licensing Opportunities

April 2, 2003

By Cormac Sheridan

BioXell Moves BXL-628 Into Phase II Clinical Trial For BPH

April 2, 2003

By Cormac Sheridan

Basilea Planning Phase III Trial Of Lead Drug For Hand Dermatitis

March 26, 2003

By Cormac Sheridan

Biovitrum Moves Diabetes Drug Into Controlled Phase II Study

March 26, 2003

By Cormac Sheridan

Biovitrum Moves Diabetes Drug Into Controlled Phase II Study

March 26, 2003

By Cormac Sheridan

Basilea Planning Phase III Trial Of Lead Drug For Hand Dermatitis

March 26, 2003

By Cormac Sheridan

OncoGenome Sciences Raises EUR14M For Cancer Diagnostics

March 19, 2003

By Cormac Sheridan

OncoGenome Sciences Raises EUR14M For Cancer Diagnostics

March 19, 2003

By Cormac Sheridan

Irish Foundation's Grants For IT, For Life Sciences Nears EUR200M

March 12, 2003

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...